Patterns of familial aggregation of three melanoma risk factors: Great number of naevi, light phototype and high degree of sun exposure

International Journal of Epidemiology

Volumn 29, Issue 3, 2000, Pages 408-415

  Briollais, Laurent ^a   Chompret, Agnès ^b   Guilloud Bataille, Michel ^c   Bressac De Paillerets, Brigitte ^b   Avril, Marie Françoise ^b   Demenais, Florence ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM   (France)

Author keywords

Familial aggregation; Generalized estimating equations; Melanoma; Naevus; Phototype; Sun exposure

Indexed keywords

PROTEIN P16;

ADULT; ARTICLE; AUTOSOME; CANCER RISK; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FRANCE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; SIBLING; SPOUSE; SUN EXPOSURE;

EID: 0033937631     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/intjepid/29.3.408     Document Type: Article

References (38)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol. VII. IARC Scientific Publication No. 143. Lyon: International Agency for Research on Cancer, 1997.
2. Ménégoz F, Chérié-Challine L. Le Cancer en France: Incidence et Mortalité, Situation en 1995. Evolution entre 1975 et 1995. Réseau Francim et Direction Générale de la Santé, Ministère de l'Emploi et de la Solidarité. Edité par la Documentation Française, 1998.
3. Grob JJ, Gouvernet J, Aymar D et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990;66:387-93.
4. Garbe C, Büttner P, Weiss J et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi and actinic lentigines. J Invest Dermatol 1994;102:700-05.
5. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 1995;141:934-42.
6. Bliss JM, Ford D, Swerdlow AJ et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 1995;62:367-76.
7. Greene M, Fraumeni J. The hereditary variant of malignant melanoma. In: Clark WH, Goldman LI, Mastrangelo MJ (eds). Human Malignant Melanoma. New York: Grune and Straton, 1979, pp. 139-66.
8. Hussussian C, Sreuewing J, Goldstein A et al. Germline p16 mutations in familial melanoma. Nature Genet 1994;8:15-21.
9. Kamb A, Stattuck-Eidens D, Eeles R et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 1994;8:22-26.
10. Zuo L, Weger J, Yang Q et al. Germline mutations in the p16ink4a binding domain of CDK4 in familial melanoma. Nature Genet 1996; 12:97-99.
11. Soufir N, Avril MF, Chompret A et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet 1998;7:209-16.
12. ink4 gene in Australian melanoma kindreds. Hum Mol Genet 1995;4:1845-52.
13. Holland EA, Beaton SC, Becker TM et al. Analysis of p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 1995;11: 2289-94.
14. Aitken JF, Duffy DL, Green A, Youl P, MacLennan R, Martin NG. Heterogeneity of melanoma risk in families of melanoma. Am J Epidemiol 1994;11:961-73.
15. Grange F, Chompret A, Guilloud-Bataille M et al. Comparison between familial and non familial melanoma in France Arch Dermatol 1995;131:1154-59.
16. Demenais F, Chompret A, Guilloud-Bataille M, Grange F, Avril MF. Interaction between genetic and epidemiological risk factors in cutaneous malignant melanoma in France. Am J Hum Genet 1996; 59(Suppl.):A28.
17. Briollais L, Chompret A, Guilloud-Bataille M, Feingold N, Avril MF, Demenais F. Genetic and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of nevi. Genet Epidemiol 1996;13:385-402.
18. Fitzpatrick TB. The validity and praticability of sun-reactive skin type I through VI. Arch Dermatol 1988;124:869-71.
19. Zhao LP, Lemarchand L. An analytical method for assessing patterns of familial aggregation in case-control studies. Genet Epidemiol 1992; 9:141-54.
20. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
21. Zhao LP, Prentice RL. Correlated binary regesion using a quadratic exponential model. Biometrika 1990;77:642-48.
22. Clark W, Reimer R, Greene M, Ainsworth A, Mastrangelo M. Origin of familial malignant melanoma from heritable melanocytic lesions: the B-K mole syndrome. Arch Dermatol 1978;114:732-38.
23. Lynch H, Frichot B, Lynch J. Familial atypical multiple mole melanoma syndrome. J Med Genet 1978;15:352-56.
24. Elder D, Greene M. The Dysplastic Nevus Syndrome: our definition. Am J Dermatol Pathol 1982;4:455-60.
25. Bale S, Chakravarti A, Greene M. Cutaneous malignant melanoma and familial dysplastic nevi: evidence for an autosomal dominance and pleiotropy. Am J Hum Genet 1986;38:188-96.
26. Easton D, Cox G, MacDonald M, Ponder B. Genetic susceptibility to naevi: a twin study. Br J Cancer 1991;64:1164-67.
27. Martin NG, Green AC, Ward PJ. Moliness, p16 and melanoma: a twin study. Melanoma Res 1997;7(Suppl.1):S26.
28. Goldgar D, Cannon-Albright L, Meyer L, Piepkorn M, Zone JJ, Skolnick M. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 1991;83:1726-33.
29. Zhao LP, Grove J, Quiaoit F. A method for assessing patterns of familial resemblance in complex human pedigrees, with an application to the nevus-count data in Utah kindreds. Am J Hum Genet 1992; 51:178-90.
30. Risch N, Sherman S. Genetic analysis workshop 7: summary of the melanoma workshop. Cytogenet Cell Genet 1992;59:148-58.
31. McGregor B, Pfitzner J, Zhu G et al. Genetic and environmental contributions to size color, shape, and other characteristics of melanocytic nevi in a sample of adolescent twins. Genet Epidemiol 1999; 16:40-53.
32. Goldstein A, Martinez M, Tucker MA, Demenais F. Interaction between dysplastic nevi and p16 in American melanoma-prone families. Genet Epidemiol 1998;15:518.
33. Zhu G, Duffy DL, Eldridge A et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 1999;65:483-92.
34. Clark P, Stark AE, Walsh RJ, Jardine R, Martin NG. A twin study of skin reflectance. Ann Hum Biol 1981;8:529-41.
35. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of the melanocyte hormone receptor gene are associated with red hair and fair skins in humans. Nature Genet 1995;11:328-30.
36. Valverde P, Healy E, Sikkink S et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996;5:1663-66.
37. Gruis NA, van der Velden PA, Sandkuijl LA, Bergman W, Frants RR. Variants of the melanocyte-stimulating hormone receptor gene modify melanoma risk in familial atypical multiple mole-melanoma (FAMMM) syndrome families. Melanoma Res 1997;7(Suppl.1):S9.
38. Cannon-Albright LA, Meyer LJ, Goldgar DE et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 1994;54:6041-44.